AGP Picks
View all

Informing on health and wellness news in Illinois

Provided by AGP

The Illinois Wellness Insider: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.

Press releases published on May 18, 2026

Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs
Recludix Pharma to Present at RBC Capital Markets Global Healthcare Conference
Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option
Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase
BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards
Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies
Provectus Biopharmaceuticals Reports Oral PV-10 Anti-Tumor Activity in Preclinical Bladder Cancer Study; Long-Term Survivors Show Absence of Gross Bladder Tumor at Study End
Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026
Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Novastra Therapeutics Appoints Chief Financial Officer as Company Advances Lead Candidate Toward Global Clinical Development
Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
BrainsWay Announces Minority-Stake Investment in Hopemark Health

Share us

on your social networks:

Sign up for:

The Illinois Wellness Insider

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.